GLP-1-Fc-PYY

N/A

Report date: 2025/03/20 14:48:37
NME

Base Information

Drug NameGLP-1-Fc-PYY
Drug Alias Namedual GLP-1/PYY-Y2 receptor agonist (AstraZeneca)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuropeptide Y receptor type 2 agonistsGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptorNeuropeptide Y receptor type 2
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceuticals LpAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A